Int. J. Mol. Sci. 2013, 14(12), 24412-24421; doi:10.3390/ijms141224412
Editorial

Biological Functional Relevance of Asymmetric Dimethylarginine (ADMA) in Cardiovascular Disease

1 Department of Medicine and Science of Aging, University G. D'Annunzio-Chieti, Chieti 66100, Italy 2 Intensive Cardiology Care Unit, San Camillo de Lellis Hospital, San Severo (FG) 71016, Italy
* Author to whom correspondence should be addressed.
Received: 29 October 2013; in revised form: 5 December 2013 / Accepted: 6 December 2013 / Published: 16 December 2013
(This article belongs to the Special Issue ADMA and Nitrergic System)
PDF Full-text Download PDF Full-Text [257 KB, uploaded 16 December 2013 15:25 CET]
Abstract: There is growing evidence that increased levels of the endogenous NO synthase inhibitor asymmetric dimethylarginine (ADMA) may contribute to endothelial dysfunction. Studies in animal models as well as in humans have suggested that the increase in ADMA occurs at a time when vascular disease has not yet become clinically evident. ADMA competitively inhibits NO elaboration by displacing L-arginine from NO synthase. In a concentration-dependent manner, it thereby interferes not only with endothelium-dependent, NO-mediated vasodilation, but also with other biological functions exerted by NO. The upshot may be a pro-atherogenic state. Recently, several studies have investigated the effect of various therapeutical interventions on ADMA plasma concentrations.
Keywords: ADMA; nitric oxide; cardiovascular disease

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Franceschelli, S.; Ferrone, A.; Pesce, M.; Riccioni, G.; Speranza, L. Biological Functional Relevance of Asymmetric Dimethylarginine (ADMA) in Cardiovascular Disease. Int. J. Mol. Sci. 2013, 14, 24412-24421.

AMA Style

Franceschelli S, Ferrone A, Pesce M, Riccioni G, Speranza L. Biological Functional Relevance of Asymmetric Dimethylarginine (ADMA) in Cardiovascular Disease. International Journal of Molecular Sciences. 2013; 14(12):24412-24421.

Chicago/Turabian Style

Franceschelli, Sara; Ferrone, Alessio; Pesce, Mirko; Riccioni, Graziano; Speranza, Lorenza. 2013. "Biological Functional Relevance of Asymmetric Dimethylarginine (ADMA) in Cardiovascular Disease." Int. J. Mol. Sci. 14, no. 12: 24412-24421.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert